COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04252430
Recruitment Status : Terminated (Due to other phase 3 trial failure to meet primary endpoint)
First Posted : February 5, 2020
Last Update Posted : May 13, 2020
Eurofins Optimed
Information provided by (Responsible Party):
MedDay Pharmaceuticals SA

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : March 17, 2020
Actual Study Completion Date : March 17, 2020